Organ Preservation Solutions Market, By Solution Type (Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solutions, Others), By Technique Type (Hypothermic Perfusion Preservation, Static Cold Storage, Others)

Organ Preservation Solutions Market, By Solution Type (Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solutions, Others), By Technique Type (Hypothermic Perfusion Preservation, Static Cold Storage, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Organ preservation involves removal of organs from the bodies, which are then stored for transplantation. Organ preservation systems are exclusively prepared and maintained according to the biological environment (temperature and oxygen) needed to store particular organs. Different body organs require specific and suitable storage conditions to maintain their anatomical and physiological processes. Important parameters in organ preservation include delivering of high quality organs to the donors, matching the patient and organ suitability, and restart of life of the organs and sustaining functions after the transplantation. Organ transplantation process starts with removing the needed organ from the donor body, then the organ is stored and transported.
Restraints of the Global Organ Preservation Solutions Market
Major factors hampering the growth of the organ preservation solutions market during the forecast period constitutes of advent of stem cells, and high costs.
Key features of the study:
This report provides in-depth analysis of the global organ preservation solutions market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global organ preservation solutions market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Dr. Franz Köhler Chemie GmbH, BioLife Solutions, XVIVO Perfusion AB, Bristol-Myers Squibb, Inc., and ToleroTech, Inc., Lifeline Scientific, Preservation Solutions Inc., Claris Injectables Limited, 21st Century Medicine, Paragonix Technologies Inc., BioTime, Inc. CryoLife, Inc., and Dr. Franz Köhler Chemie GmbH.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global organ preservation solutions market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Organ Preservation Solutions Market, By Solution Type:
Viaspan
Custodiol HTK
Renograf
Hypothermosol
Perfadex
Lifor
HBS Solution
siRNA Transplant Solutions
Others
Global Organ Preservation Solutions Market, By Technique Type:
Hypothermic Perfusion Preservation
Static Cold Storage
Others
Global Organ Preservation Solutions Market, By Geography:
North America
By Solution Type
Viaspan
Custodiol HTK
Renograf
Hypothermosol
Perfadex
Lifor
HBS Solution
siRNA Transplant Solutions
Others
By Technique Type
Hypothermic Perfusion Preservation
Static Cold Storage
Others
By Country:
U.S.
Canada
Europe
By Solution Type
Viaspan
Custodiol HTK
Renograf
Hypothermosol
Perfadex
Lifor
HBS Solution
siRNA Transplant Solutions
Others
By Technique Type
Hypothermic Perfusion Preservation
Static Cold Storage
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Solution Type
Viaspan
Custodiol HTK
Renograf
Hypothermosol
Perfadex
Lifor
HBS Solution
siRNA Transplant Solutions
Others
By Technique Type
Hypothermic Perfusion Preservation
Static Cold Storage
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Solution Type
Viaspan
Custodiol HTK
Renograf
Hypothermosol
Perfadex
Lifor
HBS Solution
siRNA Transplant Solutions
Others
By Technique Type
Hypothermic Perfusion Preservation
Static Cold Storage
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Solution Type
Viaspan
Custodiol HTK
Renograf
Hypothermosol
Perfadex
Lifor
HBS Solution
siRNA Transplant Solutions
Others
By Technique Type
Hypothermic Perfusion Preservation
Static Cold Storage
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Solution Type
Viaspan
Custodiol HTK
Renograf
Hypothermosol
Perfadex
Lifor
HBS Solution
siRNA Transplant Solutions
Others
By Technique Type
Hypothermic Perfusion Preservation
Static Cold Storage
Others
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Teva Pharmaceutical Industries Ltd.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Dr. Franz Köhler Chemie GmbH
BioLife Solutions
XVIVO Perfusion AB
Bristol-Myers Squibb, Inc.
ToleroTech, Inc.
Lifeline Scientific
Preservation Solutions Inc.
Claris Injectables Limited
21st Century Medicine
Paragonix Technologies Inc.
BioTime, Inc.
CryoLife, Inc.
“*” marked represents similar segmentation in other categories in the respective section.